Posts

Showing posts from August, 2020

R3 Stem Cell International Program for Stroke | Dr. David Greene Arizona

R3 Stem Cell International is now offering a new program for stroke patients at its Mexico clinic, mentioned Dr. David Greene Arizona , founder and CEO of R3 Stem Cell. The stroke treatment includes upwards of 200 million stem cells and starts at only $8975. When it comes to stroke therapy, traditional options typically fall short for significant recovery and entail potential risks. When it comes to regenerative therapies, R3 International has had excellent success with stem cell treatment for stroke patients at its Tijuana clinic. Depending on the patient's stroke history, treatment will include between 90 million and 200 million stem cells in either a 5-day stay or with four visits over a year. Initially, patients have a free phone consultation with an R3 Stem Cell licensed and experienced stem cell doctor. Options for stem cell therapy for stroke in Mexico include either IV therapy, intrathecal, or both. If a patient desires simply a one-time treatment, that option

R3 Including Exosomes with Stem Cell Therapy for Autism | Dr. David Greene Arizona

R3 International is now including exosomes with its stem cell therapy program in Mexico for autism. They have been shown to be an effective, safe option for autism patients. Stem cell and exosome therapy for autism have shown excellent outcomes at R3 International in Tijuana, with the procedures performed by licensed, expert doctors, mentioned Dr. David Greene Arizona . The doses of biologic are calculated based on the patient's weight. Up to 200 million stem cells are included, along with over 100 billion exosomes. R3 Stem Cell autism treatment with regenerative biologics has been very safe and each patient (and family) receives an escort from San Diego to the treatment clinic in Mexico. The autism stem cell treatment center is only twenty minutes from the San Diego International Airport. According to R3 CEO Dr. David Greene , MD, MBA, "Our autism program includes first-rate biologics with very high cell counts. Safety is paramount, and the lab's safety standards exceed

R3 International New Program for Knees Stem Cell Therapy | Dr. David Greene Arizona

R3 Stem Cell International is offering a new program for stem cell therapy for knees in Mexico. As Dr. David Greene Arizona mentioned that the program includes either 30 or 50 million live stem cells in either the Tijuana or Medical clinic. Stem cell treatment for knees is a great opportunity to help patients avoid the need for potentially risky surgery, such as a joint replacement. The stem cell biologic used by R3 International in Mexico includes safety standards that actually exceed FDA regulations. Treatment for knee arthritis is only $2950 for 30 million cells, which is actually enough to treat both knees, said David Greene Orthopedic . This amounts to an exceptional offer for an amount of over 70% less than what knee therapy cost in the US. If an individual desires treatment with 50 million live stem cells, the cost is only $1000 more. This is enough to treat four joints for a patient who has arthritis in several areas. According to R3 CEO Dr. David Greene , MD, MBA, "We kn

Four Joint Stem Cell Injections for Only $3950 by R3 International | Dr. David Greene Arizona

R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950, shared Dr. David Greene Arizona . With 50 million stem cells total, patients may choose which extremities they would like treated. Several studies have shown just how well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with a long history of accreditation and pristine safety record. The lab abides by quality assurance standards that exceed those of the FDA. Stem cell treatment for knees in Mexico at R3 works amazingly well. As David Greene Orthopedic mentioned, Patient satisfaction surveys at the center reveal that nine out of ten patients say they would have the procedure again and recommend it to friends and family. According to R3 CEO Dr. David Greene , MD, MBA, "The biologics don't need preservative and viability exceed 95%. The pureness and potency t